Almotriptan (Almotriptan Malate)

Trade Name : Almotriptan Malate

Mylan Pharmaceuticals Inc.

TABLET, FILM COATED

Strength 6.25 mg/1

ALMOTRIPTAN MALATE Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Serotonin 1b Receptor Agonists [MoA]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Almotriptan (Almotriptan Malate) which is also known as Almotriptan Malate and Manufactured by Mylan Pharmaceuticals Inc.. It is available in strength of 6.25 mg/1 per ml. Read more

Almotriptan (Almotriptan Malate) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • No data
  • Almotriptan tablets are a 5HT receptor agonist (triptan) indicated for:
  • Important Limitations:
  • No data
  • 2.2n- 2.3
  • Almotriptan Tablets, USP are available containing 8.75 mg or 17.50 mg of almotriptan malate, USP equivalent to 6.25 mg or 12.5 mg of almotriptan, respectively.
  • Tablets: 6.25 mg and 12.5 mg ()
  • No data
  • 4.5n- 4.6
  • No data
  • 5.5n- 7.3
  • 4.4n- 5.7
  • Serious cardiac reactions, including myocardial infarction, have occurred following the use of almotriptan (almotriptan malate) tablets. These reactions are extremely rare and most have been reported in patients with risk factors predictive of CAD. Reactions reported in association with triptans have included coronary artery vasospasm, transient myocardial ischemia, myocardial infarction, ventricular tachycardia, and ventricular fibrillation .
  • The following adverse reactions are discussed in more detail in other sections of the labeling:
  • Adverse events were assessed in controlled clinical trials that included 1840 adult patients who received one or two doses of almotriptan tablets and 386 adult patients who received placebo. The most common adverse reactions during treatment with almotriptan tablets were nausea, somnolence, headache, paresthesia, and dry mouth. In long-term open-label studies where patients were allowed to treat multiple attacks for up to 1 year, 5% (63 out of 1347 patients) withdrew due to adverse experiences.
  • Adverse events were assessed in controlled clinical trials that included 362 adolescent patients who received almotriptan tablets and 172 adolescent patients who received placebo. The most common adverse reactions during treatment with almotriptan tablets were dizziness, somnolence, headache, paresthesia, nausea, and vomiting. In a long-term, open-label study where patients were allowed to treat multiple attacks for up to 1 year, 2% (10 out of 420 adolescent patients) withdrew due to adverse events.
  • Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.
  • The most common adverse reactions (u2265 1% and greater than placebo) are:
  • To report SUSPECTED ADVERSE REACTIONS, contact Mylan Pharmaceuticals Inc. at 1-877-446-3679 (1-877-4-INFO-RX) or FDA at 1-800-FDA-1088 or
  • No data
  • 4.5n- 7.1
  • 4.6n- 7.2
  • 5.5n- 7.3
  • No data
  • 2.2n- 8.6
  • 2.3n- 8.7
  • No data
  • Almotriptan tablets, USP contain almotriptan malate, a selective 5-hydroxytryptamine (5-HT) receptor agonist. Almotriptan malate is chemically designated as 1-[[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]sulfonyl]pyrrolidine (u00b1)-hydroxybutanedioate (1:1) and its structural formula is:
  • Its molecular formula is CHNOSu2022CHO, representing a molecular weight of 469.56. Almotriptan malate, USP is a white to light yellow color crystalline powder that is soluble in water. Almotriptan tablets for oral administration contain 8.75 mg or 17.50 mg of almotriptan malate equivalent to 6.25 mg or 12.5 mg of almotriptan, respectively. Each compressed tablet contains the following inactive ingredients: hypromellose, mannitol, microcrystalline cellulose, polyethylene glycol, povidone, sodium starch glycolate (potato), sodium stearyl fumarate and titanium dioxide.
  • No data
  • No data
  • No data
  • Almotriptan Tablets, USP are available containing 8.75 mg or 17.50 mg of almotriptan malate, USP equivalent to 6.25 mg or 12.5 mg of almotriptan, respectively.
  • The 6.25 mg tablets are white to off-white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:
  • NDC 0378-5245-85carton of 6 unit-dose tablets (1 x 6)
  • The 12.5 mg tablets are white to off-white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:
  • NDC 0378-5246-85carton of 12 unit-dose tablets (2 x 6)
  • Store at 20u00b0 to 25u00b0C (68u00b0 to 77u00b0F). [See USP Controlled Room Temperature.]
  • Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
  • Advise the patient to read the FDA-approved patient labeling (Patient Information).
  • Drug Interactions: n- [see and and ]
  • Hypersensitivity:n- [see ]
  • Risk of Myocardial Ischemia and/or Infarction, Other Adverse Cardiac Events, Other Vasospasm-Related Events, and Cerebrovascular Events: n- [see , , , and ]
  • Serotonin Syndrome: n- [see ]
  • Medication Overuse Headache:u00a0n- [see ]
  • Pregnancy: n- [see ]
  • Nursing Mothers: n- [see ]
  • Ability to Operate Machinery or Vehicles:
  • This Patient Information has been approved by the U.S. Food and Drug Administration
  • Manufactured for:n Morgantown, WV 26505 U.S.A.
  • Manufactured by:n Hyderabad u2014 500 096, IndiaCode No.: MH/DRUGS/25/NKD/89
  • 75061692
  • Revised: 5/2017MX:ALMT:R3U
  • NDC 0378-5245-85
  • Almotriptann- Tablets, USP
  • 6.25 mg*
  • Rx onlyu00a0u00a0u00a0u00a0u00a06 Unit-dose Tablets (1 Card x 6 Tablets)
  • *Each film-coated tablet contains8.75 mg of almotriptan malate, USPequivalent to 6.25 mg of almotriptan.
  • Usual Dosage:
  • Store at 20u00b0 to 25u00b0C (68u00b0 to 77u00b0F).n- [See USP Controlled Roomn- Temperature.]
  • Keep this and all medication out ofn- the reach of children.
  • Manufactured for:n n Morgantown, WV 26505 U.S.A.
  • Made in India
  • Code No.: MH/DRUGS/25/NKD/89
  • Mylan.com
  • MX:5245:6C:R3
  • NDC 0378-5246-85
  • Almotriptann- Tablets, USP
  • 12.5 mg*
  • Rx onlyu00a0u00a0u00a0u00a0u00a012 Unit-dose Tablets (2 Cards x 6 Tablets)
  • *Each film-coated tablet contains17.50 mg of almotriptan malate, USPequivalent to 12.5 mg of almotriptan.
  • Usual Dosage:
  • Store at 20u00b0 to 25u00b0C (68u00b0 to 77u00b0F).n- [See USP Controlled Roomn- Temperature.]
  • Keep this and all medication out ofn- the reach of children.
  • Manufactured for:n n Morgantown, WV 26505 U.S.A.
  • Made in India
  • Code No.: MH/DRUGS/25/NKD/89
  • Mylan.com
  • MX:5246:12C:R3

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Dossiers and Stability Studies

Dossiers and Stability Studies

STABILITY STUDIES STABILITY, BA / BE STUDIES Due to our active

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71247 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.